14:00pm Chair Introduction 

Chairperson: Sven Kili, Principal, Sven Kili Consulting

14:05pm Presentation: Founding a Collaborative Economy for Translational Medicine 

• The Problem: Cost and risk hinder a sustainable scaling-out of translational medicine to meet the needs of rare genetic disease patients 
• The Solution: Decentralized Science is an emerging movement to bring greater collaboration to the discovery of, and access to the benefits of, technical innovation  
• The Application: Found a decentralized economy for sharing the cost and risk required to translate genetic therapies from the lab into the clinic 

Chris Williams, Principal Engineer, DeSci Applied Research

14:20pm Presentation:

Daniella Kranjac, Founder, Dynamk Capital  

14:35 Presentation: Introducing a New Model and Measures to Support Promising Academic Derived Advanced Therapies

• LifeArc – Assisting the translation of science to impact patients through research, funding and translational advice   
• Exploration of UK-based non-dilutive sources of funding.   
• Addressing a funding gap: The LifeArc Gene Therapy Innovation Fund 

Anji Miller, Skills Lead, Innovation Hubs for Gene Therapies, Senior Business Manager, lifeArc

14:50pm Closing Panel with Q&A 

With all session participants and joined by:

Ingrid Gafanhão, Equity Research Analyst, Healthcare, Bryan, Garnier & Co.